Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets

Witkiewicz, Agnieszka K., McMillan, Elizabeth A., Balaji, Uthra, Baek, GuemHee, Lin, Wan-Chi, Mansour, John, Mollaee, Mehri, Wagner, Kay-Uwe, Koduru, Prasad, Yopp, Adam, Choti, Michael A., Yeo, Charles J., McCue, Peter, White, Michael A., Knudsen, Erik S.·2015·Nature Communications
DOI 10.1038/ncomms7744

Cited by (1,000)

Items 901–1,000 of 1,000

  1. A phase 1b study of OXIRI in pancreatic adenocarcinoma patients and its immunomodulatory effects
    Matthew Chau Hsien Ng, Sylvia Chen, Whee Sze Ong, Akhila Balachander, Amanda Oon Lim Seet, Joe Poh-Sheng Yeong, Natalia Sutiman, Tony Kiat Hon Lim, Bernett Teck Kwong Lee, Yu Amanda Guo et al. · 2022 · International Journal of Cancer
  2. CRISPR/Cas9 engineering offers new opportunities to model pancreatic ductal adenocarcinoma development
    Claus Jørgensen, Elizabeth K. J. Hogg · 2016 · Translational Cancer Research
  3. Emerging Therapeutic Targets in Pancreatic Adenocarcinoma
    Jennifer Hsing Choe, James L. Abbruzzese · 2018 · Springer eBooks
  4. Recent Advances in Chromatin Mechanisms Controlling Pancreatic Carcinogenesis
    Thomas P. Hank, Andrew Scott Liss · 2018 · Epigenomes
  5. Alteration of Transforming Growth Factor β Signaling Pathway Predicts Worse Prognosis in Pancreatic Ductal Adenocarcinoma
    Li Mao, Ang Li, Xiaochen Zhao, Shengzhong Hou, Shan Lu, Yu Mou, Xubao Liu, Shangli Cai, Dan Cao, Bole Tian · 2020 · Pancreas
  6. Combined SHP2 and ERK inhibition for the treatment of KRAS-driven Pancreatic Ductal Adenocarcinoma
    Katrin J. Ciecielski, Antonio Mulero‐Sánchez, Alexandra Berninger, Laura Ruiz Cañas, Astrid R. Bosma, Kıvanç Görgülü, Nan Wu, Kalliope Nina Diakopoulos, Ezgi Kaya-Aksoy, Dietrich Alexander Ruess et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  7. Aberrant Signaling Pathways in Cancer
    Luca Grumolato, Stuart A. Aaronson · 2022 · Wiley eBooks
  8. Molecular Diagnostics and Genomic Profiling in Individualized Therapies of Gastrointestinal Cancers
    Mandana Kamgar, Wolfgang Michael Korn · 2019 · Springer eBooks
  9. A mucinous cystic neoplasm of the pancreas containing an undifferentiated carcinoma component and harboring the NRAS driver mutation
    Etsuko Hisanaga, Takaaki Sano, Yuka Yoshida, Norihiro Ishii, Ken Shirabe, Hayato Ikota · 2021 · Clinical Journal of Gastroenterology
  10. Neues zur Therapie des Pankreaskarzinoms: Hoffnung am Horizont?
    Anna Silvia Wenning, Christoph O. Ryser, Andréas Andreou, Beat Gloor, Martin D. Berger · 2021 · Schweizer Gastroenterologie
  11. Endoscopic Ultrasound-Guided Fine-Needle Biopsies to Generate Preclinical Disease Models to Study Inflammation in Pancreatic Ductal Adenocarcinoma
    Joanne Lundy, Daniel Gerald Croagh · 2023 · Methods in molecular biology
  12. A Humanized Patient-Derived Xenograft Model for Pancreatic Cancer
    Joanne Lundy · 2024 · Methods in molecular biology
  13. Diagnostic and Prognostic Markers for Pancreatitis and Pancreatic Ductal Adenocarcinoma
    Havish Sairaju Kantheti, Michael A. Hale, Shreoshi Pal Choudhuri, Huocong Huang, Xudong Wang, Yalda Zolghadri, Giulio Innamorati, Sai Prasada Rao Manikonda, N. Rami Reddy, Sarthak Reddy et al. · 2024 · International Journal of Molecular Sciences
  14. Consistency of a clinical decision support system with molecular tumour board recommendations for tumour sequencing-guided treatment of pancreatic cancer
    Maximilian Kordes, Linnéa Malgerud, Jan‐Erik Frödin, Jeffrey Yachnin, Carlos Fernández Moro, Sam H. Ghazi, Raffaella Pozzi Mucelli, Nikolaos Kartalis, Poya Ghorbani, Marco Del Chiaro et al. · 2024 · ESMO Gastrointestinal Oncology
  15. Inactivation of HIPK2 attenuates KRASG12D activity and prevents pancreatic tumorigenesis
    Silvia Sozzi, Isabella Manni, Cristiana Ercolani, Maria Grazia Diodoro, Armando Bartolazzi, Francesco Spallotta, Giulia Piaggio, Laura Monteonofrio, Silvia Soddu, Cinzia Rinaldo et al. · 2024 · Journal of Experimental & Clinical Cancer Research
  16. A stratified two-stage tumor molecular profiling algorithm to identify clinically actionable molecular alterations in pancreatic cancer
    Saskia Hussung, Dilara Akhoundova, Clelia Pistoni, Daniela M. Lenggenhager, Antonia Töpfer, Chantal Pauli, BC Pestalozzi, Christian Britschgi, Martin Zoche, Markus Rechsteiner et al. · 2025 · ESMO Gastrointestinal Oncology
  17. RBM10 suppresses malignant transformation in endometrial cancer via the Hippo-YAP signaling pathway
    Wei Shi · 2025 · American Journal of Translational Research
  18. Identification of KANK1 as a tumor suppressor gene in pancreatic ductal adenocarcinoma
    Gibeom Kim, Yoonho Cha, Sung Hee Baek · 2025 · Biochemical and Biophysical Research Communications
  19. Molecular analysis highlights TREM2 as a discriminating biomarker for patients suffering from pancreatic ductal adenocarcinoma
    Dimitrios Papakonstantinou, Haiding Wang, Mohamed Amine Bani, Kevin Mulder, Garett Dunsmore, Alice Boilève, Gérôme Jules-Clément, Leonardo G. Panunzi, Leslie Robert de Sousa, Carlos de la Calle‐Fabregat et al. · 2025 · Cancer Treatment and Research Communications
  20. Novel paradigms in KRAS targeting: Unveiling strategies to combat drug resistance
    Xiyuan Luo, Feihan Zhou, Yuemeng Tang, Xiaohong Liu, Ruilin Xiao, Minzhi Gu, Jialu Bai, Decheng Jiang, Gang Yang, Lei You et al. · 2025 · Chinese Medical Journal
  21. Characteristics of KRAS WT pancreatic adenocarcinomas: results of a large French multicentric cohort
    Noémie Trystram, Jerome F. Cros, Hélène Blons, Simon Garinet, Rémy Nicolle, Delphine Le Corre, Shu Lin Zhao, Jim Joseph Biagi, Alexandre Harlé, Thierry Conroy et al. · 2025 · Therapeutic Advances in Medical Oncology
  22. Nuclear VAV1 increases GLI1-dependent transcription in pancreatic cancer cells
    Brooke R Tader, Luciana L. Almada, Murat Toruner, Kayla C. LaRue-Nolan, David L. Marks, Ashley N. Sigafoos, Laura Hilario-Garcia, Vladimir G. Gainullin, Daniel D. Billadeau, Martín E. Fernández-Zapico · 2025 · Journal of Biological Chemistry
  23. MondoA mediates transcriptional coordination between the MYC network and the integrated stress response in pancreatic cancer
    Erin L. Ramsey, Stephanie Dobersch, Brian W. Freie, Nan Hyung Hong, Xiaoying Wu, Sita Kugel, Robert N. Eisenman, Patrick A. Carroll · 2026 · Proceedings of the National Academy of Sciences
  24. Targeting intratumoral heterogeneity in pancreatic cancer with sequential TIL infusions
    Lucas C. M. Arruda, Julia Karbach, Dragan Kiselicki, Evgueni Sinelnikov, Dirk Gustavus, Hans Hoffmeister, Akin Atmaca, Elke Jäger · 2026 · Cytotherapy
  25. Identification of natural compounds targeting the KRAS G12D mutation in pancreatic cancer through integrated in silico and in vitro approaches
    Mohamed Asif Shajahan, Ravichandran Jayasuriya, Tamilvanan Thangarasu, Kunka Mohanram Ramkumar · 2026 · Journal of Computer-Aided Molecular Design
  26. Peptides as integrative modulators for clinical prognosis and targeted therapy in pancreatic cancer
    Bhawana Yadav, Shiva Prasad Kollur, Amena Ali, Payas Arora, Aanika Gupta, P. Saranraj, Vijay Jagdish Upadhye, Pallavi Singh · 2026 · Discover Oncology
  27. Multi-modal digital twin model outperforms conventional biomarker stratification in pancreatic cancer
    Matthew Griffiths, Jennifer Jane Knox, Grainne M. O'Kane, Trevor J. Pugh, Julie M. Wilson, Anna Dodd, Sandra Elisabeth Fischer, Robert C. Grant, Faiyaz Notta, Steve Gallinger et al. · 2026 · Frontiers in Artificial Intelligence
  28. Clonal heterogeneity in human pancreatic ductal adenocarcinoma and its impact on tumor progression
    Despoina Kalfakakou, Daniel Cameron, Emily A. Kawaler, Motoyuki Tsuda, Lidong Wang, Qi Su, Sungsik Kim, Elektra Manolakos, Xiaohong Jing, Cristina Hajdu et al. · 2026 · Nature Genetics
  29. Intratumor Heterogeneity: Predicting and Preventing Therapeutic Resistance
    Dimosthenis E. Ziogas, Ioannis Zerdes, Efstathios G. Lykoudis, Georgios K. Glantzounis, Dimitrios H Roukos · 2016 · Biomarkers in Medicine
  30. Molecular Alterations in Pancreatic Cancer
    Toru Furukawa · 2017 · Springer eBooks
  31. Cell Cycle Machinery and Its Alterations in Pancreatic Cancer
    Yusuke Kojima, Reeja S. Maskey, Yuichi Machida · 2018 · Springer eBooks
  32. Personalisierte Krebsmedizin
    Steffen Ormanns · 2018 · Der Pathologe
  33. Mouse models of pancreatic cancer: An ever-emerging arm of cancer drug discovery
    Koelina Ganguly, Surinder K. Batra, Sukhwinder Kaur · 2019 · Elsevier eBooks
  34. The Role of BRAF Gene in Cancer: Literature Review and Future Directions
    Ricardo Hsieh · 2020 · Journal of cancer research updates
  35. Pancreatic Carcinogenesis
    Valentin Taucher, Johannes Haybaeck · 2017 · Springer eBooks
  36. Genome analyses of pancreatic ductal adenocarcinoma: Current status and future perspectives
    Toru Furukawa · 2022 · Suizo
  37. A novel necroptosis-related LncRNA signature for prediction of prognosis and therapeutic responses of head and neck squamous cell carcinoma
    Zilu Meng, Wenhan Yang, Lei Zhu, Wanyu Liu, Yudong Wang · 2022 · Frontiers in Pharmacology
  38. Molecular Profiling and Precision Medicine for Pancreatic Cancer
    Michael Jon Pishvaian, Jonathan Robert Brody · 2022 · Springer eBooks
  39. RNA sequencing reveals the transcriptomic landscape and alternative splicing events induced by LGALS1 silencing in non-small cell lung cancer
    Hongyang Shi, Yonghong Zhang, Juan Liu, Yu Wang, Ping Fang · 2023 · Advances in Clinical and Experimental Medicine
  40. The contribution of new methods in cytology for increasing sensitivity in the diagnosis of extrahepatic bile duct lesions
    Daniela Kurfürstová, Zuzana Slobodová, Vincent Zoundjiekpon, Ondřej Urban · 2023 · Biomedical Papers
  41. Metastatic pancreatic cancer with activating BRAF V600E mutations: A case report
    Fang Li, Feng Shen · 2025 · World Journal of Clinical Cases
  42. Recent Advancement in Drug Targeting Therapies in the Treatment of Pancreatic Cancer
    Ranjit Kumar Harwansh, Junainah Abd Hamid, Pranay Wal, Rohitas Deshmukh, Pratap Kumar Patra, Amin Gasmi · 2025 · Current Pharmaceutical Design
  43. Pancreatic adenocarcinoma in a patient with a germline RB1 pathogenic variant
    Riya Jayesh Patel, Christos K Fountzilas, Michael Horowitz, Emily Schultz, Katherine M Clayback, Erik S. Knudsen, Agnieszka Katarzyna Witkiewicz, Kenan Onel · 2025 · Familial Cancer
  44. Molecular pathogenesis of pancreatic ductal adenocarcinoma
    Sangeetha N. Kalimuthu, Faiyaz Notta · 2016 · Diagnostic histopathology
  45. Vaccine Therapy in Pancreatic Cancer
    Benjamin Adam Weinberg, Michael Jon Pishvaian · 2017 · Springer eBooks
  46. Genomic Applications in Pancreatic and Gastric Tumors
    Fátima Carneiro, Ralph H. Hruban · 2018 · Springer eBooks
  47. Mutational landscape of pancreatic cancer and genomic analysis using EUS-FNA samples
    Kentaro Sudo, Sana Yokoi · 2018 · Suizo
  48. The epigenomic impact of methylation in metabolic dysfunction and cancer
    Cynthia A. Zahnow · 2019 · Elsevier eBooks
  49. Evolving trends in pancreatic cancer therapeutic development
    Imani Bijou, Jin Wang · 2019 · Annals of Pancreatic Cancer
  50. Exploiting Kinase Inhibitors for Cancer Treatment: An Overview of Clinical Results and Outlook
    Athina Anastasia Moschopoulou, Stefan Zwirner, Lars Zender, Daniel Dauch · 2020 · Topics in medicinal chemistry
  51. PDAC Subtypes/Stratification
    Holly Brunton, Giuseppina Caligiuri, Gareth J. Inman, Peter J. Bailey · 2020 · Molecular and translational medicine
  52. Molecular Subtyping of Pancreatic Cancer
    Stephan B. Dreyer, Nigel Balfour Jamieson, David Kuang-Fu Chang, Andrew Victor Biankin · 2021 · Springer eBooks
  53. Dense array of floating water droplets aligned to an assembly of tubular wells
    Yuzuru Shimazaki, Akiko Shiratori, Kunio Harada, Tatsuo Nakagawa, Junko Tanaka, Chihiro Uematsu · 2021 · Japanese Journal of Applied Physics
  54. Establishment and Characterization of a New Pancreatic Ductal Adenocarcinoma Cell Line Capan-26
    Eglė Žalytė, Veronika Dedonytė, Benediktas Kurlinkus, Audrius Šileikis, Peter Schemmer, Mindaugas Valius · 2021 · Anticancer Research
  55. Targeting MYC to Combat Pancreatic Cancer
    Yuhong Liu, Yi‐Xiang Gan, Jun-Zong Chen, Yaxin Jiang, Fei Huang, Di Tang · 2022 · Journal of Exploratory Research in Pharmacology
  56. From bench to bedside: Pursuing equity in precision medicine approaches to pancreatic cancer care
    Kelly M. Herremans, Andrea N. Riner, Angel M. Charles, Jeremy A. Balch, Vignesh Vudatha, Devon C. Freudenberger, Ibrahim Nassour, Steven J. Hughes, Jose Gilberto Trevino, Tyler John Loftus · 2022 · Frontiers in Oncology
  57. Desenvolvimento de xenotransplantes de tumores pancreáticos humanos para varredura genética de alvos moleculares com potencial terapêutico
    Luis Bruno da Cruz e Alves de Moraes · 2019 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  58. The functional landscape of patient derived RNF43 mutations predicts Wnt inhibitor sensitivity
    Jia Yu, Permeen Akhtar Bt Mohamed Yuso, Pamela Goh, Nathan Harmston, David Mark Epstein, David M. Virshup, Babita Madan · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  59. Arid1a Haploinsufficiency Initiates Neural Crest Transformation in a Mouse Model of Mycn-driven Neuroblastoma
    Kirby A. Wallace · 2020
  60. Mutations in TP53 and other heterogeneous genes help to distinguish metastases from new primary malignancies
    Owen W.J. Prall, Ravikiran Vedururu, Peter K. H. Lau, ANDREW P. FELLOWES · 2020 · medRxiv
  61. Staging Classification and Stratification of Pancreatic Cancer for Clinical Practice
    Akhil Chawla, Andrew J. Aguirre · 2021 · Wiley eBooks
  62. Multi-dimensional analyses identify genes of high priority for pancreatic cancer research
    Zeribe C. Nwosu, Heather Giza, Maya Nassif, Verodia Charlestin, Rosa Elena Menjivar, Daeho Kim, Samantha B. Kemp, Nina G. Steele, Jiantao Hu, Biao Hu et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  63. Gene Co-Expression Network Characterizing Microenvironmental Heterogeneity and Intercellular Communication in Pancreatic Ductal Adenocarcinoma: Implications of Prognostic Significance and Therapeutic Target
    Chengsi Wu, Yizhen Liu, Kun Cai, Liyuan Tao, Dianhui Wei, Tiantian Jing, Boshi Wang · 2021 · Research Square
  64. ARID1A: guardian of normal pancreatic ducts
    Karla J. Castellanos, Paul J. Grippo · 2019 · Translational Cancer Research
  65. Text-based Integration of Mutational Profiles for Classification and Biomarker Identification of Intraductal Papillary Mucinous Neoplasms of the Pancreas
    Nam Quoc Nguyen, Jamie K. Teer, Margaret A. Park, Francisca Beato, Patricia H. McDonald, Jason B. Fleming, Jennifer B. Permuth, Kwang‐Cheng Chen, Aleksandra M. Karolak · 2023 · medRxiv
  66. Molecular Understanding of the Development of Ductal Pancreatic Cancer
    Jae Woo Lee, Ralph H. Hruban, Laura DeLong Wood · 2023 · Wiley eBooks
  67. Simultaneous Targeting of KRAS and CDK4 Synergistically Suppresses Pancreatic Cancer Cells
    Maj-Britt Paulsohn, Klara Henrike Frahnert, Xin Fang, Carolin Schneider, Constanza Tapia Contreras, Günter Schneider, Elisabeth Heßmann, Matthias Dobbelstein · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  68. MondoA mediates transcriptional coordination between the MYC network and the integrated stress response in pancreatic ductal adenocarcinoma
    Erin L. Ramsey, Stephanie Dobersch, Brian W. Freie, Nan Hyung Hong, Xiaoying Wu, Sita Kugel, Robert N. Eisenman, Patrick A. Carroll · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  69. METHOD Open Access
    Lasse Maretty, Jonas A. Sibbesen, Anders Krogh · 2014
  70. Early Detection and Treatment Opportunities in Pancreatic Adenocarcinoma
    Eileen Mary O'Reilly · 2016 · Journal of Oncology Practice
  71. Pancreatic cancer: molecular genomics and clinical applications
    Shinichi Yachida, Erina Takai · 2016 · Suizo
  72. Quoi de neuf en recherche fondamentale et translationnelle sur le cancer du pancréas ?
    Louis Buscail, Barbara Bournet · 2015 · ONCOLOGIE
  73. Cancers du pancréas : articulation entre la recherche fondamentale et la recherche clinique
    Christelle de la Fouchardière, Laëtitia Dahan · 2015 · ONCOLOGIE
  74. Epigenetic Alterations in Pancreatic Cancer
    Jiaqi Shi · 2016 · Pancreas - Open Journal
  75. A study into the effect of RBM5 expression on a small cell lung cancer cell line
    Justin G. Roy · 2016 · Lu Zone Ul (Laurentian University)
  76. Slicing and Dicing Pancreatic Cancer Into Actionable Nuggets
    Anirban Maitra · 2017 · Journal of the National Comprehensive Cancer Network
  77. O papel da quinase Aurora A na biologia das células iniciadoras de turmor pulmonares com mutação em KRAS
    Luiza Coimbra Scalabrini · 2017 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  78. Elucidating the role of SMAD7 in pancreatic cancer through in vivo studies
    Sudha S. Savant · 2017 · IUScholarWorks (Indiana University)
  79. Molecular Understanding of Development of Ductal Pancreatic Cancer
    Laura DeLong Wood, Ralph H. Hruban · 2018 · Wiley eBooks
  80. GENETIC EVOLUTION AND PROGNOSTIC DETERMINANTS OF PANCREATIC CANCER ON LONGITUDINAL LIQUID BIOPSIES
    Vincent Bernard · 2018 · Digital Commons-TMC (Texas Medical Center)
  81. Targeting the Epigenome as a Therapeutic Strategy for Pancreatic Tumors: DNA and Histone Modifying Enzymes
    Sathish Kumar Mungamuri · 2019 · Elsevier eBooks
  82. Duktales Adenokarzinom des Pankreas
    Eike Gallmeier, Thomas Mathias Gress · 2019 · Die Gastroenterologie
  83. Chromatin remodelling controls pancreatic tissue fate
    Elisabeth Heßmann, Volker Ellenrieder · 2019 · Gut
  84. The Effect of Cancer-Associated SETD2 Mutations on Transcription and Chromatin Organization
    Catherine C. Fahey · 2019 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
  85. Evaluating the therapeutic potential of the PAK1 and TBK1 kinases in pancreatic ductal adenocarcinoma
    Nicole M. Baker · 2019 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
  86. Maligne Tumoren der Bauchspeicheldrüse
    Bernhard Willibald Renz, Jan Goesta D’Haese, Jens Werner · 2019 · CME
  87. Loss of TIP30 Accelerates Pancreatic Cancer Progression and Metastasis
    Imasuen Williams, E Imade · 2019
  88. Case of Invasive Carcinoma Derived from Intraductal Papillary Mucinous Neoplasm Negative for GNAS Mutation
    Nobuhiko Fukuba, Shunji Ishihara, Ichiro Moriyama, Yasunari Kawabata, Yoshitsugu Tajima · 2019 · Cureus
  89. Role of stromal SPARC in PDAC tumorigenesis and drug delivery
    Iswarya Ramu · 2019 · eDiss (Georg-August-Universität Göttingen)
  90. Advances in identifying coding variants of common complex diseases
    Minglong Cai, Delin Ran, Xuejun Zhang · 2019 · Journal of Bio-X Research
  91. Targeting the epigenome as a therapeutic strategy for pancreatic tumors
    Sathish Kumar Mungamuri · 2019 · Elsevier eBooks
  92. Pancreatic ductal adenocarcinoma with mismatch repair deficiency resected after long-term observation
    Nobuhiko Ogasawara, Tsunao Imamura, Rikako Koyama, Naoko Inoshita, Atsuhito Nakayama, Daisuke Hattori, Yasuo Ito, Yoshiki Sato, Tetsuo Tamura, Masaji Hashimoto · 2020 · Clinical Journal of Gastroenterology
  93. Molecular Biology of Biliopancreatic Lesions
    Michela Visani, Giorgia Acquaviva, Annalisa Pession, Giovanni Tallini, Dario de Biase · 2020 · Springer eBooks
  94. Molecular and morphologic study of pancreatic cancer evolution
    Michaël Noë · 2020 · Utrecht University Repository (Utrecht University)
  95. Anotação e caracterização de novos transcritos expressos no adenocarcinoma de pâncreas: RNAS não-codificadores longos associados a fenótipos tumorais e clínicos e formas alternativas de splicing
    Vinicius Ferreira da Paixão · 2019 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  96. Rescue and Repair of Collapsed Replication Forks
    Kelvin W. Pond · 2019 · UA Campus Repository (The University of Arizona)
  97. Insertional mutagenesis defines drivers and evolutionary relationships in pancreatic cancer metastasis
    Suman Govindaraju, Michelle M. Maurin, Justin Y. Newberg, Devin J. Jones, Hubert Lee, Judit E. Markovitz, Michael B. Mann, Michael A. Black, Karen M. Mann · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  98. Integration of Genomic and Transcriptomic Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Metastases
    Ashton Anthony Connor, Robert Edward Denroche, Gun Ho Jang, Mathieu Lemire, Amy Xin Wei Zhang, Michelle Chan‐Seng‐Yue, Gavin W. Wilson, Daniele Merico, Ilinca M. Lungu, John M.S. Bartlett et al. · 2018 · SSRN Electronic Journal
  99. INO80 Chromatin Remodelling Coordinates Metabolic Homeostasis with Cell Division
    Graeme J. Gowans, Alicia N. Schep, Ka Man Wong, Devin A. King, William James Greenleaf, Ashby J. Morrison · 2018 · SSRN Electronic Journal
  100. Characterization of the relationship between two RBM5 family members
    Julie J. Loiselle · 2017 · Lu Zone Ul (Laurentian University)